Literature DB >> 31966380

Expression of beta adrenergic receptor in oral squamous cell carcinoma and its significance to the prognosis.

Hao Dong1,2, Xian-Xiang Liao1, Hua-Ming Mai1, Nuo Zhou1, Dai-You Wang1, Jian-Bo Peng1, Liang-Hui Yang1.   

Abstract

The aim of this study was to detect the expression of β-AR (Beta Adregenic Receptor) in Oral squamous cell carcinoma (OSCC), para-cancerous and normal oral mucosa and to investigate the relationship between the expression intensity and the characteristics and prognosis of oral cancer. 100 cases of OSCC were collected; 20 cases of paraneoplastic tissues and 10 cases of normal oral mucosa were taken as control. The expression of β-AR was detected by immunohistochemical method and the average optical density determination using Image J software. Finally, the difference of β-AR expression and the correlation with the clinicopathological factors were analyzed statistically. The expression of β-AR in OSCC was higher than that in paracarcinoma and normal mucosa (P<0.01). The expression intensity of β1, β2-AR in preoperative lymph node metastasis group was higher than that in patients without lymph node metastasis (P<0.01). The expression intensity of β3-AR was not related to pathological grade and tumor size (P>0.05). β1 and β2-AR in early stage of OSCC were higher than those in early stage (P<0.05). Lymph node metastasis, recurrence, TNM clinical stage, and the expression intensity of β1-AR all had an effect on the cumulative survival rate. All the β1, 2, 3-AR were expressed in OSCC. β1 and β2-AR were involved in lymphatic metastasis and had influence on clinical staging. Metastasis, recurrence, TNM stage and expression of β1-AR had an effect on the cumulative survival rate of tumor. The expression of β3-AR in OSCC was not associated with the pathological grades and tumor growth. IJCEP
Copyright © 2017.

Entities:  

Keywords:  Oral squamous cell carcinoma; lymph node; metastasis; prognosis; β-adrenergic receptor

Year:  2017        PMID: 31966380      PMCID: PMC6965752     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  3 in total

1.  α1 adrenergic receptors in serum and saliva of patients with oral squamous cell carcinoma.

Authors:  Narges Gholizadeh; Amir-Hossein Mohebbi; Iraj Mirzaii-Dizgah; Nafiseh Sheykhbahaei
Journal:  Clin Transl Oncol       Date:  2021-03-01       Impact factor: 3.405

2.  Expression pattern and clinical significance of beta 2-adrenergic receptor in oral squamous cell carcinoma: an emerging prognostic indicator and future therapeutic target.

Authors:  Akhilesh Krishna; Vineeta Singh; Nishtha Singh; Shraddha Singh; Sujit Kumar Mohanty; Rajender Singh; Vijay Kumar; Uma Shankar Singh; Rakesh Kumar Singh
Journal:  Clin Transl Oncol       Date:  2022-08-02       Impact factor: 3.340

3.  Cervical Cancer Imaging Features Associated With ADRB1 as a Risk Factor for Cerebral Neurovascular Metastases.

Authors:  Xingju Zheng; Shilin Xu; JiaYing Wu
Journal:  Front Neurol       Date:  2022-07-12       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.